Mangesh Tiwaskar

ORCID: 0000-0003-4024-0095
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Diabetes Management and Research
  • Diabetes Treatment and Management
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Diabetes Management and Education
  • Blood Pressure and Hypertension Studies
  • COVID-19 Clinical Research Studies
  • Obesity and Health Practices
  • Diet and metabolism studies
  • Pharmacology and Obesity Treatment
  • Diabetes and associated disorders
  • Liver Disease Diagnosis and Treatment
  • SARS-CoV-2 and COVID-19 Research
  • Dietary Effects on Health
  • Pharmaceutical Practices and Patient Outcomes
  • Mobile Health and mHealth Applications
  • Pancreatic function and diabetes
  • Cardiovascular Function and Risk Factors
  • Nutrition and Health in Aging
  • Lipoproteins and Cardiovascular Health
  • Hormonal Regulation and Hypertension
  • Vitamin D Research Studies
  • Gestational Diabetes Research and Management
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Metabolism, Diabetes, and Cancer
  • Thyroid Disorders and Treatments

Shilpa (India)
2017-2025

Academy of Family Physicians of India
2016-2024

Bombay Hospital
2017-2023

Jubilee Mission Medical College and Research Institute
2022

Bharti Hospital
2017

This guideline addresses the use of hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) in patients >18 years with chronic kidney disease (CKD) and anemia South Asia (Bangladesh, Bhutan, Nepal, India, Pakistan, Sri Lanka). It also summarizes recommendations for treatment individual HIF-PHI molecules under two categories: dialysis-dependent non-dialysis-dependent CKD patients. The do not apply to pediatric (≤12 years) adolescent (12 18) or those primary secondary other causes...

10.25259/ijn_389_23 article EN Indian Journal of Nephrology 2025-02-25

Abstract: Diabetes and obesity are both increasing at a fast pace giving rise to new epidemic called diabesity. Lifestyle interventions including diet play major role in the treatment of diabetes, There many guidelines on dietary management diabetes or globally also from South Asia. However, there no global Asian non-pharmacological Asia differs rest world as Asians have different phenotype, cooking practices, food resources exposure, medical nutrition therapy (MNT) availability trained...

10.2147/dmso.s278928 article EN cc-by-nc Diabetes Metabolic Syndrome and Obesity 2021-04-01

Denosumab, a human monoclonal antibody that exhibits strong affinity and specificity for the receptor activator of nuclear factor-kappa B ligand (RANK-L), is essential in regulating bone turnover. Its inhibition RANK-L decreases resorption by preventing development, function, survival osteoclasts. The objective study was to evaluate compare efficacy safety biosimilar denosumab with reference product, Prolia (denosumab), Indian women suffering from postmenopausal osteoporosis. This phase III...

10.59556/japi.73.0772 article EN PubMed 2025-01-01

The burden of sarcopenia in India continues to be significant concern. Its diagnosis is challenging due the lack standardized cutoffs for assessing muscle strength, quantity, and function among Indians. This consensus aims identify features Indians provide culturally relevant recommendations its management. An expert panel from diverse medical specialties across arrived at a using modified Delphi method. recommended that baseline handgrip strength (HGS) cutoff value <27.5 kg males 18.0...

10.2147/ijgm.s510412 article EN cc-by-nc International Journal of General Medicine 2025-03-01

Sodium-glucose co-transporter-2 inhibitors (SGLT2i) are a class of medications that have shown significant efficacy in regulating blood glucose levels and providing additional benefits, such as cardiorenal protection. This study aims to analyze the factors leading nonadherence discontinuation SGLT2i treatment identify strategies can enhance patient compliance reduce withdrawal rates. consensus involved an expert committee comprising 14 opinion leaders, chosen for their profound expertise...

10.59556/japi.73.0887 article EN PubMed 2025-04-01

To assess the efficacy of ambulatory glucose profiling (AGP) generated by FreeStyle LibrePro™ flash monitoring (FCGM) on glycemic control in patients with uncontrolled type 1 diabetes (T1D) and 2 (T2D).Clinical biochemical data were obtained from 5072 who had an A1c ≥7% (2536 been initiated FCGM-based AGP between March 2015 October 2016 [cases] 2536 age-, gender-, A1c-, site- time-matched controls not AGP) across seven clinics India. Anthropometric clinical measurements through standardized...

10.1089/dia.2017.0063 article EN Diabetes Technology & Therapeutics 2017-09-01

10.1016/j.dsx.2020.07.003 article EN Diabetes & Metabolic Syndrome Clinical Research & Reviews 2020-07-10

Digital therapeutic platforms facilitate health care through patient-centered strategies based on multidisciplinary teams and shared decision-making. Such can be used for developing a dynamic model of diabetes delivery, which help in improving glycemic control by promoting long-term behavior changes people with diabetes.This study aims to evaluate the real-world effectiveness Fitterfly Diabetes CGM digital therapeutics program type 2 mellitus (T2DM) after completion 90 days program.We...

10.2196/43292 article EN cc-by JMIR Diabetes 2023-03-07
Coming Soon ...